Cardiovascular risk assessment in hypertensive patients: Major discrepancy according to ESH and SCORE strategies

Journal of Hypertension

Volumn 25, Issue 4, 2007, Pages 757-762

  Lengelé, Jean Philippe ^a   Vinck, Wouter J ^b   De Plaen, Jean François ^a   Persu, Alexandre ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b SINT AUGUSTINUS HOSPITAL   (Belgium)

Author keywords

Cardiovascular risk; European Society of Hypertension; Guidelines; Hypertension; SCORE

Indexed keywords

ADULT; AGED; ARTICLE; BELGIUM; CARDIOVASCULAR RISK; COMORBIDITY; CONSTANTS AND COEFFICIENTS; DIABETES MELLITUS; DISEASE SEVERITY; ESSENTIAL HYPERTENSION; FEMALE; GENDER; GROUPS BY AGE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM;

EID: 33947185323     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328017f6fa     Document Type: Article

References (31)

1. Kannel WB. Risk stratification in hypertension: new insights from the Framingham Study. Am J Hypertens 2000; 13:3S-10S.
2. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345:1291-1297.
3. Mancia G. Total cardiovascular risk: a new treatment concept. J Hypertens 2006; 24 (Suppl):17-24.
4. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
5. Practice Guidelines Writing Committee. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 2003; 21:1779-1786.
6. Persson M, Carlberg B, Tavelin B, Lindholm LH. Doctors' estimation of cardiovascular risk and willingness to give drug treatment in hypertension: fair risk assessment but defensive treatment policy. J Hypertens 2004; 22:65-71.
7. Yikona JI, Wallis EJ, Ramsay LE, Jackson PR. Coronary and cardiovascular risk estimation in uncomplicated mild hypertension. A comparison of risk assessment methods. J Hypertens 2002; 20:2173-2182.
8. Persson M, Carlberg B, Weinehall L, Nilsson L, Stegmayr B, Lindholm LH. Risk stratification by guidelines compared with risk assessment by risk equations applied to a MONICA sample. J Hypertens 2003;21:1089- 1095.
9. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17:151-183.
10. Dawber TR, Meadors GF, Moore FE Jr. Epidemiologic approaches to heart disease: the Framingham Study. Am J Public Health 1951; 41:279-286.
11. Dawber TR, Kannel WB, Revotskie N, Stokes J 3rd, Kagan A, Gordon T. Some factors associated with the development of coronary heart disease: six years' follow-up experience in the Framingham study. Am J Public Health 1959; 49:1349-1356.
12. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24:987-1003.
13. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2003; 10:1-10.
14. Haq IU, Ramsay LE, Yeo WW, Jackson PR, Wallis EJ. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart 1999; 81:40-46.
15. Brindle P, Emberson J, Lampe F, Walker M, Whincup P, Fahey T, et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 2003; 327:1267.
16. Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 2000; 21:365-370.
17. Marrugat J, D'Agostino R, Sullivan L, Elosua R, Wilson P, Ordovas J, et al. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health 2003; 57:634-638.
18. Neuhauser HK, Ellert U, Kurth BM. A comparison of Framingham and SCORE-based cardiovascular risk estimates in participants of the German National Health Interview and examination Survey 1998. Eur J Cardiovasc Prev Rehabil 2005; 12:442-450.
19. Alvarez Cosmea A, Diaz Gonzalez L, Lopez Fernandez V, Prieto Diaz MA, Suarez Garcia S. Comparison of the SCORE and Framingham models in calculating high cardiovascular risk for a sample of males within the 45-65 age range in Asturias, Spain. Rev Esp Salud Publica 2005; 79:465-473.
20. Maiques Galan A, Anton Garcia F, Franch Taix M, Albert Ros X, Aleixandre Marti E, Collado Gil A. Cardiovascular risk of SCORE compared to Framingham. Consequences of the change proposed by the European Societies. Med Clin (Barc) 2004; 123:681-685.
21. Mostaza JM, Vicente I, Taboada M, Laguna F, Echaniz A, Garcia-Iglesias F, Lahoz C. The application of the SCORE charts to advanced age males triple the number of high-risk subjects compared to the Framingham function. Med Clin (Barc) 2005; 124:487-490.
22. Fornasini M, Brotons C, Sellares J, Martinez M, Galan ML, Saenz I, da Pena JM. Consequences of using different methods to assess cardiovascular risk in primary care. Fam Pract 2006; 23:28-33.
23. De Backer G, De Bacquer D, Brohet C, De Ceukelier S, Franck A, Krzentowsky G, et al. Recommendations relatives à la prévention des maladies cardiovasculaires en pratique clinique. Louvain Médical 2005; 4: 158-169/
24. Rev Med Liege 2005; 60:163-172.
25. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Measurement 1960; 20:37-46.
26. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K, DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004; 164:1066-1076.
27. Prentice AM. The emerging epidemic of obesity in developing countries. Int J Epidemiol 2006; 35:93-99.
28. Cuspidi C, Lonati L, Macca G, Sampieri L, Fusi V, Severgnini B, et al. Cardiovascular risk stratification in hypertensive patients: impact of echocardiography and carotid ultrasonography. J Hypertens 2001; 19:375-380.
29. Cuspidi C, Meani S, Valerio C, Fusi V, Sala C, Zanchetti A. Left ventricular hypertrophy and cardiovascular risk stratification: impact and cost-effectiveness of echocardiography in recently diagnosed essential hypertensives. J Hypertens 2006; 24:1671-1677.
30. Viazzi F, Leoncini G, Parodi D, Ratto E, Vettoretti S, Vaccaro V, et al. Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension. J Am Soc Nephrol 2005; 16:S89-S91.
31. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366:1640-649.